Home › Trial NCT00822120
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Trial IDNCT00822120
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorSWOG Cancer Research Network
- Enrollment371
- Start date2009-07
- ConditionsLymphoma · Nonneoplastic Condition
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.